# Thermo Fisher Scientific

Source: https://onco.cc/companies/thermo-fisher/  
OnCo record `thermo-fisher` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Thermo Fisher is the largest life-science tools and services company, spanning Ion Torrent sequencing (Oncomine), viral vector and fill-finish manufacturing (Patheon), and the PPD clinical research organisation.

## Summary

Thermo Fisher Scientific, based in Waltham, Massachusetts, and listed as TMO, is the largest life science tools and services company, spanning Ion Torrent sequencing with the Oncomine tests, viral vector and fill-finish manufacturing through Patheon, and the PPD clinical research organisation. Its oncology footprint includes the Oncomine Dx Target Test companion diagnostic, the Ion Torrent Genexus system, Patheon CDMO sites for viral vectors, PPD's trial services and laboratory supplies across the field, and in the first quarter of 2026 it completed the acquisition of Clario, a provider of endpoint data for clinical trials. OnCo links it to viral vector manufacturing, sterile fill-finish, CROs and companion diagnostics, and to the Oncomine Dx Target Test drug record. Whether one company supplying sequencing, manufacturing and trials creates conflicts or efficiencies is the fair question. Oncomine Dx Target Test has its own page.

## Fields

- Kind: Company
- Last checked: 2026-10-29
- Tags: supporting
- HQ: Waltham, MA
- Type: cro-services
- Website: https://www.thermofisher.com
- Ticker: TMO

## Notes

- Checked 29 October 2026. Thermo Fisher's first-quarter 2026 results release (SEC exhibit, 23 April 2026) says it completed the acquisition of Clario during the quarter; the release gives neither the exact closing date nor Clario's price, so no value is recorded here.

## Sources

- Official website: https://www.thermofisher.com
- First-quarter 2026 results, Clario acquisition completed (SEC): https://www.sec.gov/Archives/edgar/data/97745/000009774526000086/q12026earnings8kex99_1.htm

## Connected records

- fronts: [Cell Therapy](https://onco.cc/fronts/cell-therapy/), [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/), [Drug Discovery Platforms](https://onco.cc/fronts/drug-discovery/)
- technologies: [Companion diagnostics](https://onco.cc/technologies/companion-diagnostic/), [Contract research organisations (CROs)](https://onco.cc/technologies/contract-research-organisations/), [Downstream purification (Protein A capture, viral clearance, polishing)](https://onco.cc/technologies/downstream-purification-chromatography/), [Flow cytometers](https://onco.cc/technologies/flow-cytometers/), [High-throughput screening and DNA-encoded libraries](https://onco.cc/technologies/high-throughput-screening-libraries/), [mRNA and lipid nanoparticle manufacturing](https://onco.cc/technologies/mrna-lnp-manufacturing/), [Proteomics instruments and affinity platforms](https://onco.cc/technologies/proteomics-platforms/), [Single-use bioprocessing systems](https://onco.cc/technologies/single-use-bioprocessing/), [Small-molecule API synthesis](https://onco.cc/technologies/small-molecule-api-synthesis/), [Sterile fill-finish and lyophilisation](https://onco.cc/technologies/sterile-fill-finish/), [Structural biology infrastructure (cryo-EM, synchrotrons, AlphaFold)](https://onco.cc/technologies/structural-biology-infrastructure/), [Viral vector manufacturing (lentiviral, retroviral, AAV)](https://onco.cc/technologies/viral-vector-manufacturing/)
- companies: [Clario](https://onco.cc/companies/clario/)
- drugs: [Oncomine Dx Target Test](https://onco.cc/drugs/oncomine-dx-target-test/)

---
JSON: https://onco.cc/api/v1/entities/thermo-fisher.json